Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
S-1 + Oxaliplatin + Irinotecan in Advanced Biliary Tract Cancer
NCT02527824Phase 2Unknown
- Sponsor
- Hallym University Medical Center
- Start
- Mar 2015
- Primary completion
- Aug 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of tegafur in biliary tract cancer (BTC), sponsored by Hallym University Medical Center. Status: unknown.
02
Drugs
tegafur
03
Conditions
biliary tract cancer (BTC)
Beyond the preview
Go deeper on NCT02527824.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02527824.